Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
LOTTI, TORELLO
and
HAUTMANN, GIUSEPPE
1993.
ATYPICAL MYCOBACTERIAL INFECTIONS: A DIFFICULT AND EMERGING GROUP OF INFECTIOUS DERMATOSES.
International Journal of Dermatology,
Vol. 32,
Issue. 7,
p.
499.
Leggiadro, Robert J.
1993.
Pediatric antimicrobial therapy.
Current Problems in Pediatrics,
Vol. 23,
Issue. 8,
p.
315.
ROTMAN, DARRIN A.
BLAUVELT, ANDREW
and
KERDEL, FRANCISCO A.
1993.
WIDESPREAD PRIMARY CUTANEOUS INFECTION WITH MYCOBACTERIUM FORTUITUM.
International Journal of Dermatology,
Vol. 32,
Issue. 7,
p.
512.
Stein, Gary E.
Mummaw, Nancy L.
and
Havlichek, Daniel H.
1995.
A Preliminary Study of Clarithromycin versus Doxycycline in the Treatment of Nongonococcal Urethritis and Mucopurulent Cervicitis.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 15,
Issue. 6,
p.
727.
Clark, J E
Magee, J G
and
Cant, A J
1995.
Non-tuberculous mycobacterial lymphadenopathy..
Archives of Disease in Childhood,
Vol. 72,
Issue. 2,
p.
165.
Barber, Peter G.
Goldman, William M.
Avicolli, Annette J. Stahl
Smith, Rosemary
Rairden, Neal
Maragni, Octavio
Chirico, Jeneane
and
Mangone, Constance
1995.
Tuberculosis.
p.
252.
VilmGnyi, E.
Küng, K.
Riond, J.‐L.
Trümpi, B.
and
Wanner, M.
1996.
Clarithromycin pharmacokinetics after oral administration with or without fasting in crossbred beagles.
Journal of Small Animal Practice,
Vol. 37,
Issue. 11,
p.
535.
Sachs, George
1997.
Proton Pump Inhibitors and Acid‐Related Diseases.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 17,
Issue. 1,
p.
22.
Parish, Lawrence Charles
1999.
Rheumaderm.
Vol. 455,
Issue. ,
p.
397.
Lingerfelt, Brian
and
Champney, W.Scott
1999.
Macrolide and ketolide antibiotic separation by reversed phase high performance liquid chromatography.
Journal of Pharmaceutical and Biomedical Analysis,
Vol. 20,
Issue. 3,
p.
459.
Hessen, Margaret Trexler
and
Kaye, Donald
2000.
PRINCIPLES OF SELECTION AND USE OF ANTIBACTERIAL AGENTS.
Infectious Disease Clinics of North America,
Vol. 14,
Issue. 2,
p.
265.
Zuckerman, Jerry M.
2000.
THE NEWER MACROLIDES: AZITHROMYCIN AND CLARITHROMYCIN.
Infectious Disease Clinics of North America,
Vol. 14,
Issue. 2,
p.
449.
McCarty, James M.
2000.
Clarithromycin in the management of community-acquired pneumonia.
Clinical Therapeutics,
Vol. 22,
Issue. 3,
p.
281.
Jacks, S.
Gigue`re, S.
Gronwall, R. R.
Brown, M. P.
and
Merritt, K. A.
2002.
Disposition of oral clarithromycin in foals.
Journal of Veterinary Pharmacology and Therapeutics,
Vol. 25,
Issue. 5,
p.
359.
Giguére, Steeve
Jacks, Stephanie
Roberts, Gregory D.
Hernandez, Jorge
Long, Maureen T.
and
Ellis, Christina
2004.
Retrospective Comparison of Azithromycin, Clarithromycin, and Erythromycin for the Treatment of Foals withRhodococcus equiPneumonia.
Journal of Veterinary Internal Medicine,
Vol. 18,
Issue. 4,
p.
568.
Zuckerman, Jerry M
2004.
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.
Infectious Disease Clinics of North America,
Vol. 18,
Issue. 3,
p.
621.
Blondeau, Joseph M
2006.
Update on the use of the macrolides for community-acquired respiratory tract infections.
Therapy,
Vol. 3,
Issue. 5,
p.
619.
Zuckerman, Jerry M.
Qamar, Fozia
and
Bono, Bartholomew R.
2009.
Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, Tigecycline.
Infectious Disease Clinics of North America,
Vol. 23,
Issue. 4,
p.
997.
Zuckerman, Jerry M.
Qamar, Fozia
and
Bono, Bartholomew R.
2011.
Review of Macrolides (Azithromycin, Clarithromycin), Ketolids (Telithromycin) and Glycylcyclines (Tigecycline).
Medical Clinics of North America,
Vol. 95,
Issue. 4,
p.
761.
Bosnar, Martina
Čužić, Snježana
Bošnjak, Berislav
Nujić, Krunoslav
Ergović, Gabrijela
Marjanović, Nikola
Pašalić, Ivanka
Hrvačić, Boška
Polančec, Denis
Glojnarić, Ines
and
Haber, Vesna Eraković
2011.
Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia.
International Immunopharmacology,
Vol. 11,
Issue. 4,
p.
424.